Press release

Invitation to presentation of the Q3 report 2023

November 01, 2023

STOCKHOLM – November 1, 2023 – Oncopeptides AB (publ), a biotech company focused on difficult-to-treat cancers, will publish the report for the third quarter 2023 at 08:00 CET on November 8. Investors, financial analysts, and media are invited to participate in a webcast and a subsequent Q&A session on November 8 at 09:00 CET.

The presentation will be hosted by Sofia Heigis, CEO, together with Holger Lembrér, CFO. The webcast will be held in English and published on the website of Oncopeptides – – in conjunction with the start of the presentation.

Information for participants
If you wish to participate via webcast please use the link below.
If you wish to participate via teleconference please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.